Authored by: Kathy Williams, Vice President of Quality Assurance/Regulatory Affairs and Caitlin Hansen, Director of Quality Control RoosterBio Quality Excellence: we nurture a hard-working innovative culture where quality begins at ... More
Originally Authored by Jon A. Rowley, PhD, Founder (February 15, 2014), Updated by Iain Farrance, PhD Technical Marketing Associate (January 9, 2020) What’s in a Name? MSC is the traditional ... More
Authored by: Katrina Adlerz, PhD, Scientist, RoosterBio and Divya Patel, PhD, Scientist, RoosterBio MSC-EVs Emerge as a Cell-Free Therapy Extracellular vesicle (EV) interest continues to increase as more evidence emerges ... More
Authored by Joseph Candiello, Ph.D., Technical Application Specialist Figure 1. Current and emerging applications using hMSCs as a critical raw material. Human mesenchymal stem/stromal cells (hMSCs) are a critical starting ... More
INTRODUCTION: Human mesenchymal stem cells (hMSC) are currently in use in over 400 clinical trials and are critical components of tomorrow’s cell-based products and devices (1, 2, 3). The secretion ... More
By Iain Farrance, Priya Baraniak, and Jon Rowley. RoosterBio. In this blog, we will present internal data and information on priming RoosterBio’s bone marrow-derived human MSCs (hMSC) with pro-inflammatory molecules ... More
We blogged recently about Mesenchymal Stem/Stromal Cell (MSC) Misconceptions that are holding the translational cell therapy field back, as identified by Donald Phinney and Luc Sensebé. Since we have come ... More
We blogged several months ago about bottlenecks in the bioprocessing of Mesenchymal Stem Cells that are impeding their clinical translation. While the development of robust and scalable manufacturing methods, reduced ... More
From www.CellTherapyWonk.com Fall is almost here, and that means it is Cell Therapy Bioprocessing and Manufacturing conference season. This year it started a few weeks earlier as conference organizer CHI ... More
Closed system 10 layer and media bags are now readily available from several vendors. Fall is almost here, and that means it is Cell Therapy Bioprocessing and Manufacturing conference season. ... More